SCHEMBL16700182

SCHEMBL16700182

COC12CCC(NC(=O)c3cnn4c3CN(C(N)=O)CC4)(CC1)C(F)(F)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16698729 0.87 CD38 (0.31) —
SCHEMBL16700251 0.85 DRD3 (0.31) —
SCHEMBL16699389 0.77 CASR (0.31) —
SCHEMBL16699410 0.73 CSNK1E (0.40) —
SCHEMBL16700861 0.72 — —
SCHEMBL28611830 0.70 CSNK1D (0.36) —
SCHEMBL16700166 0.69 CASR (0.36) —
SCHEMBL23779001 0.66 JAK2 (0.37) —
SCHEMBL16718784 0.66 CSNK1D (0.36) —
SCHEMBL16699947 0.66 CSNK1E (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273058-B2 Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-03-01 — — US disclosed
US-20150133428-A1 NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2015-05-14 — — US disclosed
Send feedback